Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development

Semi Lim; Hye Young Cho; Dae Gyu Kim; Younah Roh; Se Young Son; Ameeq Ul Mushtaq; Minkyoung Kim; Deepak Bhattarai; Aneesh Sivaraman; Youngjin Lee; Jihye Lee; Won Suk Yang; Hoi Kyoung Kim; Myung Hee Kim; Kyeong Lee; Young Ho Jeon; Sunghoon Kim

doi:10.1038/s41589-019-0415-2

Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development

Semi Lim, Hye Young Cho, Dae Gyu Kim, Younah Roh, Se Young Son, Ameeq Ul Mushtaq, Minkyoung Kim, Deepak Bhattarai, Aneesh Sivaraman, Youngjin Lee, Jihye Lee, Won Suk Yang, Hoi Kyoung Kim, Myung Hee Kim, Kyeong Lee, Young Ho Jeon, Sunghoon Kim

Department of Pharmacy

Research output: Contribution to journal › Article › peer-review

27 Citations (Scopus)

Abstract

A tumorigenic factor, AIMP2 lacking exon 2 (AIMP2-DX2), is often upregulated in many cancers. However, how its cellular level is determined is not understood. Here, we report heat-shock protein HSP70 as a critical determinant for the level of AIMP2-DX2. Interaction of the two factors was identified by interactome analysis and structurally determined by X-ray crystallography and NMR analyses. HSP70 recognizes the amino (N)-terminal flexible region, as well as the glutathione S-transferase domain of AIMP2-DX2, via its substrate-binding domain, thus blocking the Siah1-dependent ubiquitination of AIMP2-DX2. AIMP2-DX2-induced cell transformation and cancer progression in vivo was further augmented by HSP70. A positive correlation between HSP70 and AIMP2-DX2 levels was shown in various lung cancer cell lines and patient tissues. Chemical intervention in the AIMP2-DX2–HSP70 interaction suppressed cancer cell growth in vitro and in vivo. Thus, this work demonstrates the importance of the interaction between AIMP2-DX2 and HSP70 on tumor progression and its therapeutic potential against cancer.

Original language	English
Pages (from-to)	31-41
Number of pages	11
Journal	Nature Chemical Biology
Volume	16
Issue number	1
DOIs	https://doi.org/10.1038/s41589-019-0415-2
Publication status	Published - 2020 Jan 1

Bibliographical note

Funding Information:
This work was supported by the Global Frontier Project grant (no. NRF-M3A6A4-2010-0029785) and the IMRCTR grant (no. NRF-2018R1A5A2023127) of the National Research Foundation funded by the Ministry of Science and ICT of Korea. We thank T. Otomo of The Scripps Research Institute for helpful discussions. X-ray diffraction data were collected at Pohang Accelerator Laboratory beamlines 5C, 7A and 11C and Photon Factory beamline 1A. We used the NMR instruments of the Protein Structure Group at the Korea Basic Science Institute.

Publisher Copyright:
© 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.

All Science Journal Classification (ASJC) codes

Molecular Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41589-019-0415-2

Cite this

@article{0a29d3ae496d434a8b25e7420c2ea839,

title = "Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development",

abstract = "A tumorigenic factor, AIMP2 lacking exon 2 (AIMP2-DX2), is often upregulated in many cancers. However, how its cellular level is determined is not understood. Here, we report heat-shock protein HSP70 as a critical determinant for the level of AIMP2-DX2. Interaction of the two factors was identified by interactome analysis and structurally determined by X-ray crystallography and NMR analyses. HSP70 recognizes the amino (N)-terminal flexible region, as well as the glutathione S-transferase domain of AIMP2-DX2, via its substrate-binding domain, thus blocking the Siah1-dependent ubiquitination of AIMP2-DX2. AIMP2-DX2-induced cell transformation and cancer progression in vivo was further augmented by HSP70. A positive correlation between HSP70 and AIMP2-DX2 levels was shown in various lung cancer cell lines and patient tissues. Chemical intervention in the AIMP2-DX2–HSP70 interaction suppressed cancer cell growth in vitro and in vivo. Thus, this work demonstrates the importance of the interaction between AIMP2-DX2 and HSP70 on tumor progression and its therapeutic potential against cancer.",

author = "Semi Lim and Cho, {Hye Young} and Kim, {Dae Gyu} and Younah Roh and Son, {Se Young} and Mushtaq, {Ameeq Ul} and Minkyoung Kim and Deepak Bhattarai and Aneesh Sivaraman and Youngjin Lee and Jihye Lee and Yang, {Won Suk} and Kim, {Hoi Kyoung} and Kim, {Myung Hee} and Kyeong Lee and Jeon, {Young Ho} and Sunghoon Kim",

note = "Funding Information: This work was supported by the Global Frontier Project grant (no. NRF-M3A6A4-2010-0029785) and the IMRCTR grant (no. NRF-2018R1A5A2023127) of the National Research Foundation funded by the Ministry of Science and ICT of Korea. We thank T. Otomo of The Scripps Research Institute for helpful discussions. X-ray diffraction data were collected at Pohang Accelerator Laboratory beamlines 5C, 7A and 11C and Photon Factory beamline 1A. We used the NMR instruments of the Protein Structure Group at the Korea Basic Science Institute. Publisher Copyright: {\textcopyright} 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2020",

month = jan,

day = "1",

doi = "10.1038/s41589-019-0415-2",

language = "English",

volume = "16",

pages = "31--41",

journal = "Nature Chemical Biology",

issn = "1552-4450",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development

AU - Lim, Semi

AU - Cho, Hye Young

AU - Kim, Dae Gyu

AU - Roh, Younah

AU - Son, Se Young

AU - Mushtaq, Ameeq Ul

AU - Kim, Minkyoung

AU - Bhattarai, Deepak

AU - Sivaraman, Aneesh

AU - Lee, Youngjin

AU - Lee, Jihye

AU - Yang, Won Suk

AU - Kim, Hoi Kyoung

AU - Kim, Myung Hee

AU - Lee, Kyeong

AU - Jeon, Young Ho

AU - Kim, Sunghoon

N1 - Funding Information: This work was supported by the Global Frontier Project grant (no. NRF-M3A6A4-2010-0029785) and the IMRCTR grant (no. NRF-2018R1A5A2023127) of the National Research Foundation funded by the Ministry of Science and ICT of Korea. We thank T. Otomo of The Scripps Research Institute for helpful discussions. X-ray diffraction data were collected at Pohang Accelerator Laboratory beamlines 5C, 7A and 11C and Photon Factory beamline 1A. We used the NMR instruments of the Protein Structure Group at the Korea Basic Science Institute. Publisher Copyright: © 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - A tumorigenic factor, AIMP2 lacking exon 2 (AIMP2-DX2), is often upregulated in many cancers. However, how its cellular level is determined is not understood. Here, we report heat-shock protein HSP70 as a critical determinant for the level of AIMP2-DX2. Interaction of the two factors was identified by interactome analysis and structurally determined by X-ray crystallography and NMR analyses. HSP70 recognizes the amino (N)-terminal flexible region, as well as the glutathione S-transferase domain of AIMP2-DX2, via its substrate-binding domain, thus blocking the Siah1-dependent ubiquitination of AIMP2-DX2. AIMP2-DX2-induced cell transformation and cancer progression in vivo was further augmented by HSP70. A positive correlation between HSP70 and AIMP2-DX2 levels was shown in various lung cancer cell lines and patient tissues. Chemical intervention in the AIMP2-DX2–HSP70 interaction suppressed cancer cell growth in vitro and in vivo. Thus, this work demonstrates the importance of the interaction between AIMP2-DX2 and HSP70 on tumor progression and its therapeutic potential against cancer.

AB - A tumorigenic factor, AIMP2 lacking exon 2 (AIMP2-DX2), is often upregulated in many cancers. However, how its cellular level is determined is not understood. Here, we report heat-shock protein HSP70 as a critical determinant for the level of AIMP2-DX2. Interaction of the two factors was identified by interactome analysis and structurally determined by X-ray crystallography and NMR analyses. HSP70 recognizes the amino (N)-terminal flexible region, as well as the glutathione S-transferase domain of AIMP2-DX2, via its substrate-binding domain, thus blocking the Siah1-dependent ubiquitination of AIMP2-DX2. AIMP2-DX2-induced cell transformation and cancer progression in vivo was further augmented by HSP70. A positive correlation between HSP70 and AIMP2-DX2 levels was shown in various lung cancer cell lines and patient tissues. Chemical intervention in the AIMP2-DX2–HSP70 interaction suppressed cancer cell growth in vitro and in vivo. Thus, this work demonstrates the importance of the interaction between AIMP2-DX2 and HSP70 on tumor progression and its therapeutic potential against cancer.

UR - http://www.scopus.com/inward/record.url?scp=85076179555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076179555&partnerID=8YFLogxK

U2 - 10.1038/s41589-019-0415-2

DO - 10.1038/s41589-019-0415-2

M3 - Article

C2 - 31792442

AN - SCOPUS:85076179555

SN - 1552-4450

VL - 16

SP - 31

EP - 41

JO - Nature Chemical Biology

JF - Nature Chemical Biology

IS - 1

ER -

Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this